Adagio Medical Appoints Two Seasoned Senior Executives to Accelerate Commercial Readiness 
BioAge Raises $90M to Treat Aging and Age-related Diseases
Proceeds will support advancement of the company’s pipeline and proprietary platform for identifying and developing therapies to treat diseases of...
Pandion Therapeutics Appoints Katina Dorton to its Board of Directors
WATERTOWN, Mass., Dec. 03, 2020 (GLOBE NEWSWIRE) -- Pandion Therapeutics, Inc. (Nasdaq: PAND), a clinical-stage biotechnology company developing novel therapeutics...
Innate Pharma to present additional efficacy data for monalizumab in combination with cetuximab in head and neck cancer at the ESMO immuno-oncology virtual congress
Phase 2 expansion cohort data supports ongoing Phase 3 trialMarseille, Dec. 03, 2020 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext...
Enlivex Reports Positive Interim Results From Phase II Clinical Trial Evaluating Allocetra in Severe and Critical COVID-19 Patients
Nes Ziona, Israel, Dec. 03, 2020 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage immunotherapy company,...
FDA Clears Rezolute’s IND Application for RZ402
RZ402 is an orally available plasma kallikrein inhibitor in development for the treatment of diabetic macular edemaREDWOOD CITY, Calif., Dec....
PolyPid to Host Key Opinion Leader Call Discussing D-PLEX₁₀₀ and the Prevention of Surgical Site Infections
PETAH TIKVA, Israel, Dec. 03, 2020 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD), a Phase 3 clinical-stage biopharmaceutical company focused on developing targeted,...
Research From Exergen Corporation Shows Morning-Only Temperature Readings May Miss up to Half of All Fevers
Twice Daily Temperature Taking Taking your temperature twice daily is the most accurate way to screen for fever, a leading...
iCAD Hosting Investor Webinar on Expanded ProFound AI Portfolio with New Breast Cancer Risk Assessment Solution
Leading Clinical Experts Discuss Advancing Personalized Breast Cancer Screening and Detection with Newly Launched ProFound AI Risk Added Market Growth...
CytomX Therapeutics to Present Updates on CX-2009 at 2020 San Antonio Breast Cancer Symposium
SOUTH SAN FRANCISCO, Calif., Dec. 03, 2020 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company...
Completion of Balstilimab BLA Filing Extended To 1H2021
Agenus to fulfill FDA feedback for six-month follow-up on late respondersLEXINGTON, Mass., Dec. 03, 2020 (GLOBE NEWSWIRE) -- Agenus Inc....
Vaxil Provides Business Update on Corvax™ Experiments
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Dec. 03, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO...
Cytokinetics Announces Three Presentations at the International Symposium on ALS/MND
SOUTH SAN FRANCISCO, Calif., Dec. 03, 2020 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced three poster presentations at...
Study on Patented Non-Opioid MKO Melt® Reported in Leading Peer-Reviewed Anesthesia Journal
NASHVILLE, Tenn., Dec. 03, 2020 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced that a study featuring its...
Expanding Immunoscore® clinical utility on 3000+ stage III colon cancer patients
Expanding Immunoscore® clinical utility on 3000+ stage III colon cancer patients Marseille, France, December 03, 2020 HalioDx SAS, the immuno-oncology...
Evelo Biosciences Completes Enrollment to Interim Target in Phase 2 Trial Evaluating EDP1815 for the Treatment of Psoriasis
CAMBRIDGE, Mass., Dec. 03, 2020 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq: EVLO), a clinical stage biotechnology company developing a...
Avricore’s HealthTab Expands North With Oak Medical Arts
VANCOUVER, British Columbia, Dec. 03, 2020 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”)...
reMYND commences first-in-human trial of ReS19-T Alzheimer’s program
Press Release reMYND commences first-in-human trial of ReS19-T Alzheimer’s program RES19-T represents a novel approach to treat Alzheimer’s at the...
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NEW YORK, Dec. 03, 2020 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical stage company developing transformative therapies...
EyePoint Pharmaceuticals Reports Positive Results from GLP Toxicology Study of EYP-1901, a Potential Six-month Treatment of Wet Age-related Macular Degeneration
- No unexpected safety findings during the course of the study - - On track to file an IND by...
TG Therapeutics Recaps Schedule of Data Presentations at the Upcoming 62nd American Society of Hematology Annual Meeting and Exposition
NEW YORK, Dec. 03, 2020 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today recapped the schedule of data presentations...